(MedPage Today) — A first-in-human percutaneous aorto-coronary bypass procedure, dubbed “VECTOR,” was used to prevent coronary obstruction following transcatheter aortic valve replacement in a patient ineligible for leaflet modification. (Circulation…
Source link : https://www.medpagetoday.com/cardiology/generalcardiology/119297
Author :
Publish date : 2026-01-06 18:45:00
Copyright for syndicated content belongs to the linked Source.
